205643-28-3Relevant articles and documents
Hypoxia-Targeting Organometallic Ru(II)-Arene Complexes with Enhanced Anticancer Activity in Hypoxic Cancer Cells
Zhao, Jian,Li, Wanchun,Gou, Shaohua,Li, Shuang,Lin, Shengqiu,Wei, Qianhui,Xu, Gang
, p. 8396 - 8403 (2018/07/25)
As hypoxia is an important factor to limit chemotherapeutic efficacy in tumors, we herein report three ruthenium(II)-arene complexes containing a hypoxia inducible factor-1α inhibitor (YC-1), which endow the organometallic complexes with potential for hyp
ANTI-ANGIOGENESIS COMPOUNDS
-
Page/Page column 85, (2010/11/27)
The present invention provides methods and pharmaceutical compositions for inhibiting expressions of HIF and HIF regulated genes, inhibiting angiogenesis, inducing cell cycle arrest in tumor cells, and treating cell proliferating diseases or conditions
New synthesis of 3-substituted indazoles from 3-trimethylsilylindazole
Hari, Yoshiyuki,Shoji, Yoshimichi,Aoyama, Toyohiko
, p. 1183 - 1186 (2007/10/03)
Reaction of aryl aldehydes with 3-trimethylsilylindazole in the presence of CsF easily gave the corresponding 3-(arylhydroxymethyl)indazoles in good to moderate yields.